Cardinal Health Sets $0.5107 Quarterly Dividend, Highlights Capital-Allocation Strategy

Cardinal Health sets quarterly dividend and frames capital-allocation priorities

Dividend Approval Reflects Capital-Allocation and Shareholder-Return Focus

Cardinal Health’s board approves a quarterly dividend of $0.5107 per share, payable April 15, 2026 to shareholders of record at the close of business on April 1, 2026, and declares the payment is to be made out of the company’s capital surplus. The move formalises the company’s cash-return cadence, with the quarterly rate annualising to $2.0428 per share, and signals management’s continued emphasis on balancing shareholder distributions with operational investment across its healthcare services platform.

The decision follows a pattern of communication in which Cardinal Health is reiterating financial policy while continuing to invest in distribution, manufacturing and patient-facing services. Executives frame the dividend as consistent with a “customer-centric” operating model that drives continuous improvement and innovation across pharmaceutical distribution, medical and laboratory product manufacturing, home-health supply, nuclear pharmacy operations and performance-data solutions.

Cardinal Health positions the dividend announcement as part of broader capital allocation and strategic messaging rather than an isolated financial event. The board action is presented alongside the company’s ongoing investor outreach, including recent outlook updates and conference presentations, as management seeks to show predictability in returns while maintaining flexibility to fund growth initiatives in supply chain and specialty product channels.

Business Scope and Strategic Messaging

The company emphasises its diversified role in the healthcare supply chain — distributing pharmaceuticals and specialty products, manufacturing medical and laboratory items, supplying direct-to-patient goods and operating nuclear pharmacies — and directs stakeholders to its newsroom and SEC filings for full context. The statement underlines Cardinal Health’s focus on innovation and continuous improvement across its core businesses.

Investor and Media Guidance

Cardinal Health provides contact points for media and investor inquiries and urges shareholders and interested parties to note the precise dividend amount and timing and to consult official filings for updates. The release is sourced to Cardinal Health and is positioned as a transparent update on the company’s return-of-capital practices and strategic communications.